Amylyx Pharmaceuticals, Inc. (AMLX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $332.64M | +71.8% |
| 2024 | $193.63M | -62.6% |
| 2023 | $517.45M | +32.2% |
| 2022 | $391.45M | +270.6% |
| 2021 | $105.61M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $332.64M | +71.8% |
| 2024 | $193.63M | -62.6% |
| 2023 | $517.45M | +32.2% |
| 2022 | $391.45M | +270.6% |
| 2021 | $105.61M | — |